Floatz logo

Tacrolimus

T-Cell Large Granular Lymphocyte Leukemia

University of Medicine and Dentistry of New JerseySmall moleculePhase 2Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the T-Cell Large Granular Lymphocyte Leukemia cohort.

Asset / SponsorPhaseRating
Fludarabine
Ohio State University Comprehensive Cancer Center
Phase 2BBB
Cyclosporin A
Case Comprehensive Cancer Center
Phase 2BB
Cyclophosphamide
Case Comprehensive Cancer Center
Phase 2BB
Busulfanum
Ohio State University Comprehensive Cancer Center
Phase 2BB
Rituximab
Northwestern University
Phase 2B

View all 47 →

Same molecule, other indications

Tacrolimus is also rated in:

disease related to transplantationDormant
BBB
Indicative · Phase 4
79 / 100
View asset →
disease related to solid organ transplantationDormant
BBB
Indicative · Phase 4
76 / 100
View asset →
beta-thalassemia majorDormant
BBB
Indicative · Phase 4
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →